1.A Locally Acquired Falciparum Malaria via Nosocomial Transmission in Korea.
Jung Yeon KIM ; Jeong Su KIM ; Mi Hyun PARK ; Young A KANG ; Jun Wook KWON ; Shin Hyeong CHO ; Byeong Chul LEE ; Tong Soo KIM ; Jong Koo LEE
The Korean Journal of Parasitology 2009;47(3):269-273
A 57-year old man who was admitted to an emergency room of a tertiary hospital with hemoptysis developed malarial fever 19 days later and then died from severe falciparum malaria 2 days later. He had not traveled outside of Korea for over 30 years. Through intensive interviews and epidemiological surveys, we found that a foreign patient with a recent history of travel to Africa was transferred to the same hospital with severe falciparum malaria. We confirmed through molecular genotyping of the MSP-1 gene that Plasmodium falciparum genotypes of the 2 patients were identical. It is suggested that a breach of standard infection control precautions resulted in this P. falciparum transmission between 2 patients in a hospital environment. This is the first report of a nosocomial transmission of falciparum malaria in Korea.
Africa
;
Amino Acid Sequence
;
Animals
;
Cross Infection/parasitology/*transmission
;
Fatal Outcome
;
Humans
;
Korea
;
Malaria, Falciparum/parasitology/*transmission
;
Male
;
Merozoite Surface Protein 1/chemistry/genetics
;
Middle Aged
;
Molecular Sequence Data
;
Plasmodium falciparum/chemistry/genetics/*isolation & purification
;
Protozoan Proteins/chemistry/genetics
;
Sequence Alignment
;
Travel
2.Efficacy of the Merozoite Surface Protein 1 of Plasmodium Vivax as an Antigen for ELISA to Diagnose Malaria.
Yong Man KIM ; Hyun Ah HWANG ; Woo Sang YUN ; Suk Il KIM ; Kil Whoan LEE ; Seung Kyu PARK ; Young Jin LEE ; Tae Kyun KIM ; Chansuda WONGSRICHANALAI ; Judy A SAKANARI ; Hyun PARK
Yonsei Medical Journal 2004;45(1):129-134
Malaria is still a major health problem in Thailand and its incidence is currently rising in Korea. To identify a useful antigen for the diagnosis of malaria patients, a cDNA expression library from malaria parasites was constructed and screened out immunologically. One clone was selected in view of its predominant reactivity with the patient sera. The recombinant malaria parasite antigen (Pv30) with 27 kDa as a C-terminal His-tag fusion protein that was produced in Escherichia coli was identified through immunoblot analysis. The deduced amino acid sequence had the sequence homology with the merozoite surface protein 1 (MSP1) genes of Plasmodium falciparum and P. yoelii, each by 41% and 42%, respectively. Measurement of serum IgG and IgM antibody to Pv30 by enzyme-linked immunosorbent assay (ELISA) was evaluated as a serodiagnostic test for malaria patients in Thailand (endemic area) and Korea (recently reemerging area). The sensitivity of P. vivax, P. falciparum, and P. malariae was 96.3% (26 /27), 90.6% (29/32), and 100% (6/6), respectively, and the specificity was 63.5% (40/63) in Thailand samples. The sensitivity of P. vivax was 98.8% (88/89), and the specificity was 96.6% (86/89) in Korean samples. Pv30 appears to be a good and reliable recombinant antigen for serodiagonosis of malaria in a nonendemic area.
Amino Acid Sequence
;
Animals
;
Antibodies, Protozoan
;
Enzyme-Linked Immunosorbent Assay/*methods
;
Human
;
Korea
;
Malaria, Vivax/*diagnosis/immunology
;
Merozoite Surface Protein 1/*analysis/genetics/immunology
;
Molecular Sequence Data
;
Plasmodium vivax/chemistry/immunology/*isolation & purification
;
Sensitivity and Specificity
;
Serologic Tests
;
Support, Non-U.S. Gov't